Biolase Long Term Debt 2010-2024 | BIOL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biolase long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Biolase long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Becton Dickinson (BDX)	$66.8B
McKesson (MCK)	$66.6B
Cardinal Health (CAH)	$26.9B
Cooper (COO)	$21.9B
West Pharmaceutical Services (WST)	$21.5B
Labcorp (LH)	$19.1B
Align Technology (ALGN)	$18.9B
Henry Schein (HSIC)	$9B
Merit Medical Systems (MMSI)	$5.7B
DENTSPLY SIRONA (XRAY)	$5.4B
CONMED (CNMD)	$2.3B
Patterson (PDCO)	$1.9B
STAAR Surgical (STAA)	$1.6B
Lifevantage (LFVN)	$125M
Pro-Dex (PDEX)	$83M